| abstract |
The present invention relates to purine compounds useful as kinase inhibitors. More particularly, the present invention relates to purine compounds, methods for their preparation, pharmaceutical compositions containing these compounds, and the use of these compounds in the treatment of proliferative conditions or disorders. These compounds may be useful as agents for the treatment of many proliferative conditions or disorders, including tumors and cancers as well as other conditions or disorders associated with PI3 and / or mTOR kinases. (I). |